Shudi Luo

1.3k total citations · 3 hit papers
19 papers, 750 citations indexed

About

Shudi Luo is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Shudi Luo has authored 19 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Physiology. Recurrent topics in Shudi Luo's work include Cancer, Hypoxia, and Metabolism (7 papers), Mitochondrial Function and Pathology (3 papers) and RNA Interference and Gene Delivery (3 papers). Shudi Luo is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Mitochondrial Function and Pathology (3 papers) and RNA Interference and Gene Delivery (3 papers). Shudi Luo collaborates with scholars based in China and United States. Shudi Luo's co-authors include Zhimin Lu, Dong Guo, Qingang Wu, Xiaoming Jiang, Ying Meng, Hongfei Jiang, Liwei Xiao, Yingying Tong, Haiyan He and Jing Fang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Molecular Cell.

In The Last Decade

Shudi Luo

17 papers receiving 745 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα

2022 246 citations Dong Guo, Yingying Tong et al. Cell Metabolism profile →
ACSS2 acts as a lactyl-CoA synthetase and couples KAT2A to function as a lactyltransferase for histone lactylation and tumor immune evasion

2024 100 citations Rongxuan Zhu, Xiaotong Lu et al. Cell Metabolism profile →
Glycolytic enzyme PFKL governs lipolysis by promoting lipid droplet–mitochondria tethering to enhance β-oxidation and tumor cell proliferation

2024 49 citations Ying Meng, Dong Guo et al. Nature Metabolism profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Shudi Luo	456	297	141	124	67	19	750
Davide Vecchiotti	347 0.8×	214 0.7×	121 0.9×	103 0.8×	81 1.2×	27	609
Sima Orouei	571 1.3×	379 1.3×	72 0.5×	167 1.3×	75 1.1×	19	848
He Ren	363 0.8×	281 0.9×	162 1.1×	313 2.5×	43 0.6×	20	726
Naser Jafari	424 0.9×	262 0.9×	79 0.6×	87 0.7×	29 0.4×	25	670
Zhihong Cheng	556 1.2×	194 0.7×	133 0.9×	285 2.3×	52 0.8×	26	888
Heba Alshaker	487 1.1×	157 0.5×	110 0.8×	149 1.2×	61 0.9×	24	733
Rui Han	316 0.7×	160 0.5×	94 0.7×	129 1.0×	52 0.8×	33	636
Moonmoon Deb	873 1.9×	258 0.9×	57 0.4×	153 1.2×	85 1.3×	32	1.1k
Adeline Ledoux	341 0.7×	142 0.5×	78 0.6×	126 1.0×	33 0.5×	10	545

Countries citing papers authored by Shudi Luo

Since Specialization

Citations

This map shows the geographic impact of Shudi Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shudi Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shudi Luo more than expected).

Fields of papers citing papers by Shudi Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shudi Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shudi Luo. The network helps show where Shudi Luo may publish in the future.

Co-authorship network of co-authors of Shudi Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Shudi Luo. A scholar is included among the top collaborators of Shudi Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shudi Luo. Shudi Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Zhao, Gaoxiang, Shudi Luo, Qingxia Ma, et al.. (2025). Nucleus-translocated glucokinase functions as a protein kinase to phosphorylate TAZ and promote tumour growth. Nature Communications. 16(1). 7156–7156.

Luo, Shudi, Xiaoming Jiang, Zheng Wang, et al.. (2025). Inhibition of Tumor Lipogenesis and Growth by Peptide‐Based Targeting of SREBP Activation. Advanced Science. 12(45). e08111–e08111.

Tao, Jingjing, Zheng Wang, Liming Lin, et al.. (2025). ERK–USP9X-coupled regulation of thymidine kinase 1 promotes both its enzyme activity-dependent and its enzyme activity-independent functions for tumor growth. Nature Structural & Molecular Biology. 32(5). 853–863. 2 indexed citations

He, Xuxiao, Deyu Chen, Guijun Liu, et al.. (2025). PI3Kβ functions as a protein kinase to promote cellular protein O-GlcNAcylation and acetyl-CoA production for tumor growth. Molecular Cell. 85(7). 1411–1425.e8. 4 indexed citations

Li, Shan, et al.. (2024). Short-chain fatty acids and cancer. Trends in cancer. 11(2). 154–168. 32 indexed citations

Zhu, Rongxuan, Xiaotong Lu, Liwei Xiao, et al.. (2024). ACSS2 acts as a lactyl-CoA synthetase and couples KAT2A to function as a lactyltransferase for histone lactylation and tumor immune evasion. Cell Metabolism. 37(2). 361–376.e7. 100 indexed citations breakdown →

Li, Min, Zheng Wang, Jingjing Tao, et al.. (2024). Fructose-1,6-bisphosphatase 1 dephosphorylates and inhibits TERT for tumor suppression. Nature Chemical Biology. 20(11). 1505–1513. 17 indexed citations

Meng, Ying, Dong Guo, Liming Lin, et al.. (2024). Glycolytic enzyme PFKL governs lipolysis by promoting lipid droplet–mitochondria tethering to enhance β-oxidation and tumor cell proliferation. Nature Metabolism. 6(6). 1092–1107. 49 indexed citations breakdown →

Zhao, Gaoxiang, Qingxia Ma, Yang Huang, et al.. (2023). Base editing of the mutated TERT promoter inhibits liver tumor growth. Hepatology. 79(6). 1310–1323. 8 indexed citations

10.

Tao, Jingjing, et al.. (2023). Fructose-1,6-bisphosphatase 1 suppresses PPARα-mediated gene transcription and non-small-cell lung cancer progression.. PubMed. 13(10). 4742–4754. 4 indexed citations

11.

Ma, Qingxia, Hongfei Jiang, Leina Ma, et al.. (2023). The moonlighting function of glycolytic enzyme enolase-1 promotes choline phospholipid metabolism and tumor cell proliferation. Proceedings of the National Academy of Sciences. 120(15). e2209435120–e2209435120. 66 indexed citations

12.

Guo, Dong, Yingying Tong, Xiaoming Jiang, et al.. (2022). Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα. Cell Metabolism. 34(9). 1312–1324.e6. 246 indexed citations breakdown →

13.

Guo, Dong, Haiyan He, Ying Meng, Shudi Luo, & Zhimin Lu. (2022). Determiners of cell fates: the tricarboxylic acid cycle versus the citrate-malate shuttle. Protein & Cell. 14(3). 162–164. 12 indexed citations

14.

Jiang, Hongfei, Qian Lin, Leina Ma, et al.. (2021). Fructose and fructose kinase in cancer and other pathologies. Journal of genetics and genomics. 48(7). 531–539. 22 indexed citations

15.

Tong, Yingying, Dong Guo, Yan Dong, et al.. (2019). KAT2A succinyltransferase activity-mediated 14-3-3ζ upregulation promotes β-catenin stabilization-dependent glycolysis and proliferation of pancreatic carcinoma cells. Cancer Letters. 469. 1–10. 79 indexed citations

16.

Luo, Shudi, Junlong Liu, Wei Chen, et al.. (2019). SPAG9/MKK3/p38 axis is a novel therapeutic target for liver cancer. Oncology Reports. 41(4). 2329–2336. 10 indexed citations

17.

Luo, Shudi, Xue‐Fei Tian, Zhichao Jiang, et al.. (2018). Curcumin inhibits liver cancer by inhibiting DAMP molecule HSP70 and TLR4 signaling. Oncology Reports. 40(2). 895–901. 47 indexed citations

18.

Liu, Yi, Yin Fu, Pan Chen, et al.. (2018). Inhibin B suppresses anoikis resistance and migration through the transforming growth factor‐β signaling pathway in nasopharyngeal carcinoma. Cancer Science. 109(11). 3416–3427. 28 indexed citations

19.

Luo, Shudi, Fei Xu, Guofeng Xu, et al.. (2016). The expression of DAMP proteins HSP70 and cancer-testis antigen SPAG9 in peripheral blood of patients with HCC and lung cancer. Cell Stress and Chaperones. 22(2). 237–244. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact